← Open Payments lookup

TAMAURA BAUGHMAN: Open Payments

NPI 1437520921 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$555 in 25 payments from 11 companies in 2025. Trend: 2023 $589 · 2024 $445 · 2025 $555

Food & beverage: $555
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$112
Otsuka America Pharmaceutical, Inc.5$100
Novo Nordisk Inc4$81
Corcept Therapeutics3$76
Sumitomo Pharma America, Inc.2$49
Exact Sciences Corporation2$34
Astellas Pharma US Inc1$30
Lundbeck LLC1$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$18
AstraZeneca Pharmaceuticals LP1$16

Products named: REXULTI, CAPLYTA, Korlym, Wegovy, GEMTESA, Cologuard Collection Kit, Veozah, XIFAXAN.

Industry payments across TX — which companies pay providers there.